Orforglipron and Tirzepatide Interaction

Avoid
Researched 95% confidence

Orforglipron and Tirzepatide have a potentially harmful interaction with 95% confidence. Dual GIP/GLP-1 agonist overlaps with GLP-1 mechanism; combination contraindicated. Both compounds affect the gi tract and pancreas, so monitoring these systems is recommended.

Compound Profiles

Orforglipron

Oral Small-Molecule GLP-1 Receptor Agonist | Weight Loss & Diabetes

Small-molecule GLP-1 receptor agonist with biased signaling preferentially activating G protein/cAMP pathways, enhancing insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite while minimizing receptor desensitization. 79.

Half-life: 25-68 hours Typical dose: Start 3-6mg daily, titrate up to 12-36mg based on response weight loss, metabolic
glp1 receptor teratogenic
View full profile

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist | Weight Loss & Diabetes

Dual agonist targeting both GIP and GLP-1 receptors, producing glucose-dependent insulin stimulation, delayed gastric emptying, glucagon suppression, and central satiety signaling via hypothalamic pathways..

Half-life: ~5 days (120 hours) Typical dose: 2.5mg starting, titrate up to 5-15mg weekly weight loss, metabolic
glp1 receptor teratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (Orforglipron, Tirzepatide). Monitor accordingly.

Frequently Asked Questions

Can I take Orforglipron with Tirzepatide?

Combining Orforglipron with Tirzepatide is not recommended. Dual GIP/GLP-1 agonist overlaps with GLP-1 mechanism; combination contraindicated.

Is Orforglipron and Tirzepatide safe together?

This combination carries significant risk. Dual GIP/GLP-1 agonist overlaps with GLP-1 mechanism; combination contraindicated. Consult a healthcare professional before combining.

What are the interactions between Orforglipron and Tirzepatide?

Dual GIP/GLP-1 agonist overlaps with GLP-1 mechanism; combination contraindicated. This assessment has 95% confidence and is based on documented research data.

How should I time Orforglipron and Tirzepatide?

Orforglipron has a half-life of 25-68 hours and Tirzepatide has a half-life of ~5 days (120 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Orforglipron vs Tirzepatide

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.